• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Chennai , Sept. 15

EPPENDORF India, a subsidiary of Eppendorf AG, Germany, is strengthening its presence in the biotechnology market.

The company has moved into a new facility in Chennai. A press release quoting its Chief Executive Officer, Mr Klaus Fink, said that Eppendorf's exposure in the Indian market follows the market potential and leading role of the Indian biotech industry. The company plans to keep track of the regional requirements and provide value-added services.

The new facility will include a laboratory, where its range can be showcased, and also a training centre. Eppendorf India will train customers on high-tech topics. Eppendorf AG, an equipment and research tools supplier for biotechnology companies, is looking at Asia and the Pacific region for growth. The company reported sales of 286 million euros in 2004.North America generates more than half of Eppendorf's sales. The company also has a chain of subsidiaries in Asia, including a joint venture in China.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
MRPL to raise capacity to 15 million tonne

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line